Clinical Trial: A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults

U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07385248) titled 'A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults' on Jan. 27.

Brief Summary: The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-229 and the administration of AD-2291 in healthy adults.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Gastritis

Intervention: DRUG: AD-229

AD-229 Oral Tablet

DRUG: AD-2291

AD-2291 Oral Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....